Eli Lilly & Co. shares gained as its main rival in weight-loss drugs posted disappointing results from a clinical trial.
Lilly Rises After Novo Trial Miss Boosts Its Weight Loss Edge
Estimated read time
1 min read
You May Also Like
More From Author
Hyperliquid Labs debunks DPRK links, but experts are unsure
December 23, 2024
This Classic Anime Is Somehow Even Better Than Its Legacy Would Suggest
December 23, 2024
+ There are no comments
Add yours